<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:43:59Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4608821" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:4608821</identifier>
        <datestamp>2015-10-29</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC4608821</article-id>
              <article-id pub-id-type="pmcid">PMC4608821</article-id>
              <article-id pub-id-type="pmc-uid">4608821</article-id>
              <article-id pub-id-type="pmid">26473969</article-id>
              <article-id pub-id-type="pmid">26473969</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0140312</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-15-34984</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Persistence of Hepatitis C Virus Traces after Spontaneous Resolution of Hepatitis C</article-title>
                <alt-title alt-title-type="running-head">HCV Occurrence after Self-Limiting Episode of Hepatitis</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chen</surname>
                    <given-names>Annie Y.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hoare</surname>
                    <given-names>Matthew</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shankar</surname>
                    <given-names>Arun N.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Allison</surname>
                    <given-names>Michael</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Alexander</surname>
                    <given-names>Graeme J. M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Michalak</surname>
                    <given-names>Tomasz I.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Molecular Virology and Hepatology Research Group, Faculty of Medicine, Memorial University, St. John’s, Newfoundland and Labrador, Canada</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Cancer Research UK Cambridge Institute, Cambridge, United Kingdom</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Medicine, University of Cambridge, Cambridge, United Kingdom</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Ray</surname>
                    <given-names>Ranjit</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Saint Louis University, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <fn fn-type="con" id="contrib001">
                  <p>Conceived and designed the experiments: TIM GJMA. Performed the experiments: AYC TIM. Analyzed the data: AYC TIM MH GJMA. Contributed reagents/materials/analysis tools: MH ANS MA GJMA TIM. Wrote the paper: TIM AYC MH GJMA.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>timich@mun.ca</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>16</day>
                <month>10</month>
                <year>2015</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2015</year>
              </pub-date>
              <volume>10</volume>
              <issue>10</issue>
              <elocation-id>e0140312</elocation-id>
              <history>
                <date date-type="received">
                  <day>9</day>
                  <month>8</month>
                  <year>2015</year>
                </date>
                <date date-type="accepted">
                  <day>24</day>
                  <month>9</month>
                  <year>2015</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2015 Chen et al</copyright-statement>
                <copyright-year>2015</copyright-year>
                <copyright-holder>Chen et al</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0140312.pdf"/>
              <abstract>
                <p>Hepatitis C virus (HCV) frequently causes chronic hepatitis, while spontaneous recovery from infection is infrequent. Persistence of HCV after self-limited (spontaneous) resolution of hepatitis C was rarely investigated. The current study aimed to assess incidence and robustness of HCV persistence after self-resolved hepatitis C in individuals with normal liver enzymes and undetectable virus by conventional tests. Applying high sensitivity HCV RNA detection approaches, we analyzed plasma and peripheral blood mononuclear cells (PBMC) from individuals with previous hepatitis C infection. Parallel plasma and PBMC from 24 such non-viraemic individuals followed for 0.3–14.4 (mean 6.4) years were examined. Additional samples from 9 of them were obtained 4.5–7.2 (mean 5.9) years later. RNA was extracted from 250 μl plasma and, if HCV negative, from ~5 ml after ultracentrifugation, and from <italic>ex vivo</italic> stimulated PBMC. PBMC with evidence of HCV replication from 4 individuals were treated with HCV protease inhibitor, telaprevir. HCV RNA was detected in 14/24 (58.3%) plasma and 11/23 (47.8%) PBMC obtained during the first collection. HCV RNA replicative strand was evident in 7/11 (63.6%) PBMC. Overall, 17/24 (70.8%) individuals carried HCV RNA at mean follow-up of 5.9 years. Samples collected 4.5–7.2 years later revealed HCV in 4/9 (44.4%) plasma and 5/9 (55.5%) PBMC, while 4 (80%) of these 5 PBMC demonstrated virus replicative strand. Overall, 6/9 (66.7%) individuals remained viraemic for up to 20.7 (mean 12.7) years. Telaprevir entirely eliminated HCV replication in the PBMC examined. In conclusion, our results indicate that HCV can persist long after spontaneous resolution of hepatitis C at levels undetectable by current testing. An apparently effective host immune response curtailing hepatitis appears insufficient to completely eliminate the virus. The long-term morbidity of asymptomatic HCV carriage should be examined even in individuals who achieve undetectable HCV by standard testing and their need for treatment should be assessed.</p>
              </abstract>
              <funding-group>
                <funding-statement>Canadian Institutes of Health Research, operating grant MOP-126056 - TIM. Canada Research Chair Program, Canada Research Chair Tier I in Viral Hepatitis-Immunology - TIM. Cancer Research UK, postdoctoral fellowship - MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="4"/>
                <page-count count="16"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>The HCV 5’-UTR and E1/E2 sequences identified in this study have been deposited in GenBank under accession numbers: KP861251-KP861287 and KP861318-KP861325 for 15-46/F, and KP861288-KP861317 and KP861326-KP861332 for 20-49/F.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>The HCV 5’-UTR and E1/E2 sequences identified in this study have been deposited in GenBank under accession numbers: KP861251-KP861287 and KP861318-KP861325 for 15-46/F, and KP861288-KP861317 and KP861326-KP861332 for 20-49/F.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Hepatitis C virus (HCV) is a major cause of chronic liver disease, predisposing to cirrhosis and hepatocellular carcinoma (HCC), affecting around 150 million people [<xref rid="pone.0140312.ref001" ref-type="bibr">1</xref>]. Approximately 15% of those infected undergo spontaneous resolution with loss of HCV RNA using conventional analyses [<xref rid="pone.0140312.ref002" ref-type="bibr">2</xref>]. However, HCV may establish low-level, asymptomatic, persistent infection (occult HCV infection or OCI), which can only be identified using methods with greater sensitivity than those used conventionally [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>–<xref rid="pone.0140312.ref006" ref-type="bibr">6</xref>]. This has clinical relevance since trace quantities of HCV may be infectious. Thus, 10–20 virions transmit infection to chimpanzees [<xref rid="pone.0140312.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0140312.ref008" ref-type="bibr">8</xref>], while 20–50 virions establish productive infection in cultured human T lymphocytes [<xref rid="pone.0140312.ref009" ref-type="bibr">9</xref>]. Furthermore, OCI has been identified in individuals negative for HCV RNA by conventional testing who remain asymptomatic [<xref rid="pone.0140312.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0140312.ref010" ref-type="bibr">10</xref>] and following otherwise successful antiviral therapy [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>–<xref rid="pone.0140312.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0140312.ref011" ref-type="bibr">11</xref>].</p>
              <p>Using nucleic acid amplification assays that detect HCV genomes with sensitivity below 10 copies/mL (or virus genome equivalents, vge) or &lt;2.5 vge/μg RNA (&lt;2 IU/mL), it was recognised that HCV can persist in the circulation at levels up to 100 vge/mL with continued replication in liver and peripheral blood mononuclear cells (PBMC) after sustained virological response (SVR) following IFN-based treatment [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>–<xref rid="pone.0140312.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0140312.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>]. Furthermore, plasma and PBMC collected after SVR transmitted infection to a chimpanzee causing high level viraemia and liver injury [<xref rid="pone.0140312.ref014" ref-type="bibr">14</xref>] and also productively infected HCV-prone T cells <italic>in vitro</italic> [<xref rid="pone.0140312.ref009" ref-type="bibr">9</xref>]. It is uncertain if highly potent directly acting agents (DAAs) will be more effective in purging residual HCV.</p>
              <p>Sustained persistence of trace HCV has also been reported following spontaneous resolution of HCV, but highly sensitive techniques to detect HCV RNA have been applied in only a few cases [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref015" ref-type="bibr">15</xref>]. To study this further we explored a rare collection of paired plasma and PBMC samples from patients followed up to 20 years after self-limiting HCV infection. Procedures enriching HCV by amplifying viral RNA recovered from larger amounts of plasma and from <italic>ex vivo</italic> mitogen-treated PBMC [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>–<xref rid="pone.0140312.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0140312.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>–<xref rid="pone.0140312.ref018" ref-type="bibr">18</xref>], detection of HCV RNA replicative (negative) strand and compartmentalized virus variants [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0140312.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>–<xref rid="pone.0140312.ref019" ref-type="bibr">19</xref>] and treatment of PBMC replicating HCV with a DDA [<xref rid="pone.0140312.ref020" ref-type="bibr">20</xref>] were applied to uncover the characteristics and robustness of HCV persistence. In parallel, the study aimed to assess the frequency of OCI incidence in individuals after a self-resolved episode of hepatitis C who repeatedly displayed normal liver enzyme levels and undetectable virus by conventional testing.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Materials and Methods</title>
              <sec id="sec003">
                <title>Ethic Statement</title>
                <p>The study was approved by the Research Ethics committee of Addenbrooke’s Hospital and performed in accordance with the Declaration of Helsinki. The samples were collected after signing written informed consent.</p>
              </sec>
              <sec id="sec004">
                <title>Patients and samples</title>
                <p>Paired plasma and PBMC samples were collected from 24 randomly selected, asymptomatic individuals (17 men and 7 women; aged 25 to 73 years) with spontaneous resolution of HCV, as established using recognised clinical, biochemical and virological criteria (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). Samples for the current study were obtained a mean 6.4 years (range 0.3–14.4) from first clinical review. Additional paired plasma and PBMC samples were collected from 9 individuals at a mean 5.9 years after first collection (range 4.5–7.2), <italic>i</italic>.<italic>e</italic>., a mean 12.7 years total follow-up (range 5.5 to 20.7) (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). 22/24 described risk factors for exposure to HCV, including injecting drug use (IDU) (n = 21) or multiple blood product transfusions (n = 1) (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). At first sample collection, 21/24 had normal serum alanine aminotransferase (ALT); 3/24 had minimal elevation of ALT. Total bilirubin level was normal in all. One with membranous glomerulonephritis had an abnormal prothrombin time (PT) due to anti-coagulation with warfarin. Of 8 who underwent liver biopsy, 4 had stage 1/6 fibrosis and one each had fibrosis stage 2, 3 and 5 (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). At the second sample collection, biochemical tests remained normal, except a borderline ALT in one male and the PT remained elevated in one. At that time, fibroscan showed normal liver stiffness in 8, while one male had stage 2 fibrosis (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). HCV RNA was undetectable during the entire follow-up as measured by a conventional assay (Artus HCV QS-RGQ Kit, version 1; sensitivity 20 IU/ml or 24.2 copies/ml; Qiagen Gnbh, Hilden, Germany) at approximately yearly intervals (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). All patients were anti-HCV at both sample collections (EIA; Abbott Diagnostics, Maidenhead, United Kingdom) (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). At first clinic review 13/24 were anti-HBc positive and 6 were anti-HBs positive. None was reactive for antibody to human immunodeficiency virus type-1.</p>
                <table-wrap id="pone.0140312.t001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0140312.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Clinical Characteristics and Time of Sample Collection from Individuals with Spontaneous Resolution of Hepatitis C.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0140312.t001g" xlink:href="pone.0140312.t001"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th colspan="6" align="left" rowspan="1">First Sample Collection</th>
                          <th colspan="8" align="left" rowspan="1">Second Sample Collection</th>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Case (n)</th>
                          <th align="left" rowspan="1" colspan="1">Age (Years)</th>
                          <th align="left" rowspan="1" colspan="1">Sex (F/M)</th>
                          <th align="left" rowspan="1" colspan="1">Route Of Infection</th>
                          <th align="left" rowspan="1" colspan="1">Follow-up From First Seen (Years)</th>
                          <th align="left" rowspan="1" colspan="1">ALT (0–50 U/L)</th>
                          <th align="left" rowspan="1" colspan="1">Total Bilirubin (0–17 μ/L</th>
                          <th align="left" rowspan="1" colspan="1">PT (9.8–12.6 sec)</th>
                          <th align="left" rowspan="1" colspan="1">Serum HCV RNA (Clinical Assay)<xref rid="t001fn002" ref-type="table-fn">*</xref>
</th>
                          <th align="left" rowspan="1" colspan="1">HCV Genotype</th>
                          <th align="left" rowspan="1" colspan="1">Liver Fibrosis (Stage)</th>
                          <th align="left" rowspan="1" colspan="1">Time From First Collection (Years)</th>
                          <th align="left" rowspan="1" colspan="1">ALT (0–50 U/L</th>
                          <th align="left" rowspan="1" colspan="1">Total Bilirubin (0–17 μM)</th>
                          <th align="left" rowspan="1" colspan="1">PT (9.8–12.6 Sec)</th>
                          <th align="left" rowspan="1" colspan="1">Serum HCV RNA (Clinical Assay)<xref rid="t001fn002" ref-type="table-fn">*</xref>
</th>
                          <th align="left" rowspan="1" colspan="1">Anti- HCV</th>
                          <th align="left" rowspan="1" colspan="1">Liver Fibroscan (kPa)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">38</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">Unknown</td>
                          <td align="left" rowspan="1" colspan="1">1.8</td>
                          <td align="justify" rowspan="1" colspan="1">27</td>
                          <td align="justify" rowspan="1" colspan="1">8</td>
                          <td align="justify" rowspan="1" colspan="1">13.3</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">3</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">2</td>
                          <td align="left" rowspan="1" colspan="1">45</td>
                          <td align="left" rowspan="1" colspan="1">F</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">4.8</td>
                          <td align="justify" rowspan="1" colspan="1">16</td>
                          <td align="justify" rowspan="1" colspan="1">8</td>
                          <td align="justify" rowspan="1" colspan="1">11.9</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">NA</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">46</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">1.4</td>
                          <td align="justify" rowspan="1" colspan="1">60</td>
                          <td align="justify" rowspan="1" colspan="1">7</td>
                          <td align="justify" rowspan="1" colspan="1">12.5</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1a</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">4</td>
                          <td align="left" rowspan="1" colspan="1">46</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">0.3</td>
                          <td align="justify" rowspan="1" colspan="1">21</td>
                          <td align="justify" rowspan="1" colspan="1">13</td>
                          <td align="justify" rowspan="1" colspan="1">12.6</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1b</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="char" char="." rowspan="1" colspan="1">5.2</td>
                          <td align="justify" rowspan="1" colspan="1">32</td>
                          <td align="justify" rowspan="1" colspan="1">11</td>
                          <td align="justify" rowspan="1" colspan="1">10.2</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">NA</td>
                          <td align="justify" rowspan="1" colspan="1">3.8</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">5</td>
                          <td align="left" rowspan="1" colspan="1">32</td>
                          <td align="left" rowspan="1" colspan="1">F</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">9.5</td>
                          <td align="justify" rowspan="1" colspan="1">29</td>
                          <td align="justify" rowspan="1" colspan="1">7</td>
                          <td align="justify" rowspan="1" colspan="1">12.9</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">6</td>
                          <td align="left" rowspan="1" colspan="1">25</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">0.7</td>
                          <td align="justify" rowspan="1" colspan="1">25</td>
                          <td align="justify" rowspan="1" colspan="1">13</td>
                          <td align="justify" rowspan="1" colspan="1">12.5</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">NA</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">7</td>
                          <td align="left" rowspan="1" colspan="1">73</td>
                          <td align="left" rowspan="1" colspan="1">F</td>
                          <td align="left" rowspan="1" colspan="1">Blood tx</td>
                          <td align="left" rowspan="1" colspan="1">3.3</td>
                          <td align="justify" rowspan="1" colspan="1">22</td>
                          <td align="justify" rowspan="1" colspan="1">10</td>
                          <td align="justify" rowspan="1" colspan="1">13.2</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">NA</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="char" char="." rowspan="1" colspan="1">5.5</td>
                          <td align="justify" rowspan="1" colspan="1">20</td>
                          <td align="justify" rowspan="1" colspan="1">10</td>
                          <td align="justify" rowspan="1" colspan="1">13.2</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">POS</td>
                          <td align="justify" rowspan="1" colspan="1">4</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">8</td>
                          <td align="left" rowspan="1" colspan="1">45</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">10.3</td>
                          <td align="justify" rowspan="1" colspan="1">23</td>
                          <td align="justify" rowspan="1" colspan="1">5</td>
                          <td align="justify" rowspan="1" colspan="1">11.1</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1a</td>
                          <td align="justify" rowspan="1" colspan="1">1</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">9</td>
                          <td align="left" rowspan="1" colspan="1">40</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">11.7</td>
                          <td align="justify" rowspan="1" colspan="1">31</td>
                          <td align="justify" rowspan="1" colspan="1">6</td>
                          <td align="justify" rowspan="1" colspan="1">10.3</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">NA</td>
                          <td align="justify" rowspan="1" colspan="1">0</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">10<xref rid="t001fn004" ref-type="table-fn"><sup>‡</sup></xref>
</td>
                          <td align="left" rowspan="1" colspan="1">70</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">2.3</td>
                          <td align="justify" rowspan="1" colspan="1">25</td>
                          <td align="justify" rowspan="1" colspan="1">7</td>
                          <td align="justify" rowspan="1" colspan="1">45</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1a</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="char" char="." rowspan="1" colspan="1">6.5</td>
                          <td align="justify" rowspan="1" colspan="1">18</td>
                          <td align="justify" rowspan="1" colspan="1">7</td>
                          <td align="justify" rowspan="1" colspan="1">35</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">POS</td>
                          <td align="justify" rowspan="1" colspan="1">5.7</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">11</td>
                          <td align="left" rowspan="1" colspan="1">57</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">10.4</td>
                          <td align="justify" rowspan="1" colspan="1">39</td>
                          <td align="justify" rowspan="1" colspan="1">10</td>
                          <td align="justify" rowspan="1" colspan="1">12.9</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1a</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">12</td>
                          <td align="left" rowspan="1" colspan="1">49</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">10.3</td>
                          <td align="justify" rowspan="1" colspan="1">16</td>
                          <td align="justify" rowspan="1" colspan="1">2</td>
                          <td align="justify" rowspan="1" colspan="1">12.2</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1<xref rid="t001fn005" ref-type="table-fn"><sup>§</sup></xref>
</td>
                          <td align="justify" rowspan="1" colspan="1">1</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">13</td>
                          <td align="left" rowspan="1" colspan="1">50</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">4.3</td>
                          <td align="justify" rowspan="1" colspan="1">36</td>
                          <td align="justify" rowspan="1" colspan="1">7</td>
                          <td align="justify" rowspan="1" colspan="1">10.3</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1b</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">14</td>
                          <td align="left" rowspan="1" colspan="1">47</td>
                          <td align="left" rowspan="1" colspan="1">F</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">2.9</td>
                          <td align="justify" rowspan="1" colspan="1">15</td>
                          <td align="justify" rowspan="1" colspan="1">5</td>
                          <td align="justify" rowspan="1" colspan="1">10.1</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">2a</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="char" char="." rowspan="1" colspan="1">4.5</td>
                          <td align="justify" rowspan="1" colspan="1">20</td>
                          <td align="justify" rowspan="1" colspan="1">5</td>
                          <td align="justify" rowspan="1" colspan="1">10.1</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">POS</td>
                          <td align="justify" rowspan="1" colspan="1">3.1</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">15</td>
                          <td align="left" rowspan="1" colspan="1">46</td>
                          <td align="left" rowspan="1" colspan="1">F</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">11</td>
                          <td align="justify" rowspan="1" colspan="1">20</td>
                          <td align="justify" rowspan="1" colspan="1">5</td>
                          <td align="justify" rowspan="1" colspan="1">12.2</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">3a</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="char" char="." rowspan="1" colspan="1">5.1</td>
                          <td align="justify" rowspan="1" colspan="1">28</td>
                          <td align="justify" rowspan="1" colspan="1">5</td>
                          <td align="justify" rowspan="1" colspan="1">12.2</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">POS</td>
                          <td align="justify" rowspan="1" colspan="1">3.2</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">16</td>
                          <td align="left" rowspan="1" colspan="1">52</td>
                          <td align="left" rowspan="1" colspan="1">F</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">4.8</td>
                          <td align="justify" rowspan="1" colspan="1">41</td>
                          <td align="justify" rowspan="1" colspan="1">6</td>
                          <td align="justify" rowspan="1" colspan="1">12.4</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1b</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="char" char="." rowspan="1" colspan="1">7.2</td>
                          <td align="justify" rowspan="1" colspan="1">28</td>
                          <td align="justify" rowspan="1" colspan="1">6</td>
                          <td align="justify" rowspan="1" colspan="1">12.4</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">POS</td>
                          <td align="justify" rowspan="1" colspan="1">5.8</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">17</td>
                          <td align="left" rowspan="1" colspan="1">47</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">14.4</td>
                          <td align="justify" rowspan="1" colspan="1">21</td>
                          <td align="justify" rowspan="1" colspan="1">7</td>
                          <td align="justify" rowspan="1" colspan="1">11.8</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">NA</td>
                          <td align="justify" rowspan="1" colspan="1">1</td>
                          <td align="char" char="." rowspan="1" colspan="1">6.3</td>
                          <td align="justify" rowspan="1" colspan="1">31</td>
                          <td align="justify" rowspan="1" colspan="1">11</td>
                          <td align="justify" rowspan="1" colspan="1">10.2</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">POS</td>
                          <td align="justify" rowspan="1" colspan="1">3.8</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">18</td>
                          <td align="left" rowspan="1" colspan="1">41</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">9.8</td>
                          <td align="justify" rowspan="1" colspan="1">9</td>
                          <td align="justify" rowspan="1" colspan="1">5</td>
                          <td align="justify" rowspan="1" colspan="1">13.8</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">NA</td>
                          <td align="justify" rowspan="1" colspan="1">2</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">19</td>
                          <td align="left" rowspan="1" colspan="1">55</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">Unknown</td>
                          <td align="left" rowspan="1" colspan="1">2.5</td>
                          <td align="justify" rowspan="1" colspan="1">37</td>
                          <td align="justify" rowspan="1" colspan="1">4</td>
                          <td align="justify" rowspan="1" colspan="1">11</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1</td>
                          <td align="justify" rowspan="1" colspan="1">5</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">20</td>
                          <td align="left" rowspan="1" colspan="1">49</td>
                          <td align="left" rowspan="1" colspan="1">F</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">14.3</td>
                          <td align="justify" rowspan="1" colspan="1">15</td>
                          <td align="justify" rowspan="1" colspan="1">8</td>
                          <td align="justify" rowspan="1" colspan="1">11.8</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1b</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="char" char="." rowspan="1" colspan="1">6.3</td>
                          <td align="justify" rowspan="1" colspan="1">24</td>
                          <td align="justify" rowspan="1" colspan="1">8</td>
                          <td align="justify" rowspan="1" colspan="1">11.8</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">POS</td>
                          <td align="justify" rowspan="1" colspan="1">4</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">21</td>
                          <td align="left" rowspan="1" colspan="1">27</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">2.8</td>
                          <td align="justify" rowspan="1" colspan="1">51</td>
                          <td align="justify" rowspan="1" colspan="1">7</td>
                          <td align="justify" rowspan="1" colspan="1">11.9</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">22</td>
                          <td align="left" rowspan="1" colspan="1">44</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">9.1</td>
                          <td align="justify" rowspan="1" colspan="1">8</td>
                          <td align="justify" rowspan="1" colspan="1">5</td>
                          <td align="justify" rowspan="1" colspan="1">12.8</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1a</td>
                          <td align="justify" rowspan="1" colspan="1">3</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">23</td>
                          <td align="left" rowspan="1" colspan="1">43</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">2.9</td>
                          <td align="justify" rowspan="1" colspan="1">25</td>
                          <td align="justify" rowspan="1" colspan="1">6</td>
                          <td align="justify" rowspan="1" colspan="1">12.9</td>
                          <td align="justify" rowspan="1" colspan="1">NEG</td>
                          <td align="justify" rowspan="1" colspan="1">1</td>
                          <td align="justify" rowspan="1" colspan="1">NT</td>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                          <td align="justify" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">24<xref rid="t001fn003" ref-type="table-fn"><sup>†</sup></xref>
</td>
                          <td align="left" rowspan="1" colspan="1">53</td>
                          <td align="left" rowspan="1" colspan="1">M</td>
                          <td align="left" rowspan="1" colspan="1">IDU</td>
                          <td align="left" rowspan="1" colspan="1">7.4</td>
                          <td align="left" rowspan="1" colspan="1">50</td>
                          <td align="left" rowspan="1" colspan="1">7</td>
                          <td align="left" rowspan="1" colspan="1">10.7</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">1b</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="char" char="." rowspan="1" colspan="1">6.7</td>
                          <td align="left" rowspan="1" colspan="1">50</td>
                          <td align="left" rowspan="1" colspan="1">7</td>
                          <td align="left" rowspan="1" colspan="1">12.8</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">10.7</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Mean or Number from Total</td>
                          <td align="left" rowspan="1" colspan="1">46.7</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">6.4</td>
                          <td align="left" rowspan="1" colspan="1">27.6</td>
                          <td align="left" rowspan="1" colspan="1">7</td>
                          <td align="left" rowspan="1" colspan="1">12</td>
                          <td align="left" rowspan="1" colspan="1">0/24</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">1.8</td>
                          <td align="char" char="." rowspan="1" colspan="1">5.9</td>
                          <td align="left" rowspan="1" colspan="1">27.9</td>
                          <td align="left" rowspan="1" colspan="1">7.8</td>
                          <td align="left" rowspan="1" colspan="1">11.6</td>
                          <td align="left" rowspan="1" colspan="1">0/9</td>
                          <td align="left" rowspan="1" colspan="1">8/8</td>
                          <td align="left" rowspan="1" colspan="1">4.9</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t001fn001">
                      <p>ALT, alanine aminotransferase; PT, prothrombin time; kPA, kilopescals; M, male; F, female; POS, positive; NEG, negative; NA, not available; NT, not tested; IDU, Intravenous drug user; Blood tx, blood transfusion,</p>
                    </fn>
                    <fn id="t001fn002">
                      <p>*Assay sensitivity 20 IU/m.</p>
                    </fn>
                    <fn id="t001fn003">
                      <p><sup>†</sup>Only plasma obtained during the first collection examined</p>
                    </fn>
                    <fn id="t001fn004">
                      <p><sup>‡</sup>Patient with membranous glomerulonephritis.</p>
                    </fn>
                    <fn id="t001fn005">
                      <p><sup>§</sup>Assessed by clinical test.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>PBMCs were isolated from 50–60 ml of whole blood by Ficoll-Hypaque (Pharmacia Biotech, Quebec, Canada) density gradient centrifugation and stored in liquid nitrogen [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>]. Plasma was stored at -80°C.</p>
              </sec>
              <sec id="sec005">
                <title>Stimulation of PBMC ex vivo</title>
                <p>Previous investigations of low-level (occult) infection with woodchuck hepatitis virus (WHV) and HBV [<xref rid="pone.0140312.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0140312.ref022" ref-type="bibr">22</xref>] or HCV [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0140312.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0140312.ref016" ref-type="bibr">16</xref>] demonstrated that <italic>ex vivo</italic> mitogen stimulation of lymphoid cells augments virus replication allowing detection in cells thought to be virus non-reactive. PBMC were cultured for 72 h with 5 μg/ml phytohemagglutinin (PHA; a T cell stimulating mitogen) (Sigma-Aldrich, Mississauga, Ontario, Canada) and if they remained HCV RNA negative, with C5, a cocktail containing 5 μg/ml PHA, 5 μg/ml pokeweed mitogen (a B and T cell stimulating lectin) (ICN Biomedicals, Irvine, CA), 20 U/ml interleukin-2 (IL-2; a T cell growth supporting cytokine) (Roche Molecular Diagnostics, Pleasanton, CA) and 1 ng/ml IL-4 (a B-cell growth supporting cytokine) (Roche Molecular Duiagnostics). Superiority of C5 over PHA in regard to up-regulation of HCV replication and HCV RNA expression has been reported [<xref rid="pone.0140312.ref016" ref-type="bibr">16</xref>]. PBMC were cultured as previously reported [<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0140312.ref016" ref-type="bibr">16</xref>].</p>
              </sec>
              <sec id="sec006">
                <title>RNA extraction and transcription</title>
                <p>Total RNA was extracted with Trizol LS reagent (Invitrogen) from 250 μl plasma or 5 ml plasma following ultracentrifugation at 273,800 x <italic>g</italic> for 22 h at 4°C [<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>]. RNA from 5 x 10<sup>6</sup> to 1 x 10<sup>7</sup> native or stimulated PBMC was extracted with Trizol (Invitrogen Life Technologies, Burlington, Ontario, Canada). Each series of RNA extractions were done in parallel with mock extraction using sterile water (contamination control), serum or PBMC from a healthy donor (negative control), and serum or PBMC from a patient positive for plasma HCV RNA (positive control). RNA from cells (2 to 4 μg) and all RNA obtained from plasma were transcribed to cDNA [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>].</p>
              </sec>
              <sec id="sec007">
                <title>Detection of HCV RNA positive and negative strands</title>
                <p>For detection of HCV RNA positive (replicative) strand, reverse transcriptase-polymerase chain reaction (RT-PCR) was applied using primers specific for the HCV 5ˋ-untranslated region (5ˋ-UTR), cycling conditions, quantification standards and controls reported [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0140312.ref018" ref-type="bibr">18</xref>]. Depending upon sample availability, amplification with primers specific for HCV E1/E2 region, encompassing hypervariable region 1 (HVR1), was also performed (<xref rid="pone.0140312.s001" ref-type="supplementary-material">S1 Table</xref>). Detection of HCV RNA in OCI normally requires two rounds of PCR, stringent precautions and appropriate controls at each step of RNA and cDNA preparation and PCR amplification. In all instances, signal specificity was confirmed by nucleic acid hybridization (NAH) using <sup>32</sup>P-labeled recombinant HCV 5ˋ-UTR-E2 fragment as a probe [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>]. Sensitivity of the RT-PCR/NAH assays with either 5ˋ-UTR or E1/E2 region-specific primers was ≤10 vge/mL or ≤2.5 vge/μg RNA. HCV RNA negative (replicative) strand was detected by RT-PCR/NAH, as described in detail before [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref020" ref-type="bibr">20</xref>]. This assay detects ~10<sup>2</sup> copies of the correct (negative) strand, while identifying ≥10<sup>6</sup> copies of the positive strand. Specificity of amplicons and validity of the controls was confirmed by NAH. A number of negative and contamination controls were included in each analysis [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0140312.ref018" ref-type="bibr">18</xref>].</p>
              </sec>
              <sec id="sec008">
                <title>Cloning, sequencing and HCV sequence analyses</title>
                <p>To assess possible sequence variation and compartmentalization of HCV, 5ˋ-UTR and, when available, E1/E2 amplicons were cloned using the TOPO-TA cloning system (Invitrogen). The highly conserved 5ˋ-UTR was chosen because it allows for reliable identification of most unwavering sequence variants. Up to 10 randomly selected clones were analyzed from each PCR product derived from plasma and PBMC collected from 2 individuals (15-46/F and 20-49/F) followed for 16.1 and 20.6 years, respectively. The clones were sequenced in both directions using universal forward and reverse M13 primers and the ABI-Prism 7000 Sequence Detection System (Applied Biosystems, Streetsville, Ontario, Canada).</p>
                <p>The HCV genotype was known for only one patient prior to this study (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>), so the resulting 5'-UTR sequences were aligned with help of Sequencher software version 4.7 (Gene Codes Corporation, Ann Arbor, MI). The HCV subgenotype sequences AF011751 and M62321 for genotype 1a, D90208 and D11168 for genotype 1b, AF169005 for genotype 2a, AF238486 for genotype 2b, D17763 and NC009824 for genotype 3a, and D11443 and D49374 for 3b from GenBank served as references. The phylogenetic relationships of the variant 5ˋ-UTR sequences identified in plasma and PBMC of 15-46/F and 20-49/F were analyzed with DNA-DIST in the PHYLIP (version 3) software package and trees constructed using NEIGHBOR program (University of Washington, Seattle, WA).</p>
              </sec>
              <sec id="sec009">
                <title>Treatment of HCV-infected PBMC with telaprevir</title>
                <p>Telaprevir (TLP) (Vertex Pharmaceuticals, Cambridge, MA), an HCV-specific protease inhibitor [<xref rid="pone.0140312.ref023" ref-type="bibr">23</xref>], inhibits HCV replication effectively in <italic>de novo</italic> HCV-infected T cell lines [<xref rid="pone.0140312.ref020" ref-type="bibr">20</xref>]. An established protocol was applied to determine whether HCV replication in PBMC is suppressed by treatment with TLP. Briefly, ~1x10<sup>7</sup> PBMC acquired from 14-47/F, 15-46/F and 20-49/F at 14.7 years follow up (range 7.4–20.6) (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>), reactive for HCV RNA positive and negative strands, were cultured in duplicate for 72 h in 5 ml of complete RPMI medium with 5 μg/ml PHA or C5 and 4 μM TLP in 0.5% DMSO. The same PBMC cultured in duplicate with 0.5% DMSO alone served as controls. In the preceding experiments, it was confirmed that TLP at concentrations equal to or below 4 μM in 0.5% DMSO was not toxic to normal human PBMC, as for Molt4 T cells [<xref rid="pone.0140312.ref020" ref-type="bibr">20</xref>]. Expression of HCV RNA positive and negative strands was evaluated in TLP-treated and control PBMC as indicated above.</p>
              </sec>
              <sec id="sec010">
                <title>Statistical analysis</title>
                <p>Results were analyzed by Chi-Square test using SPSS Statistics software version 19.0 (IBM, Armonk, NY). Differences between sample groups were considered to be significant when <italic>P</italic> values were below or equal to 0.05.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec011">
              <title>Results</title>
              <sec id="sec012">
                <title>Detection of HCV RNA in plasma after spontaneous resolution</title>
                <p>Paired plasma and PBMC samples were collected from 24 randomly selected, asymptomatic individuals (17 men and 7 women; aged 25 to 73 years) with spontaneous resolution of HCV, as established using recognised clinical, biochemical and virological criteria (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). Samples were obtained a mean 6.4 years (range 0.3–14.4) from first clinical review. Additional paired plasma and PBMC samples were collected from 9 individuals at a mean 5.9 years after first collection (range 4.5–7.2), <italic>i</italic>.<italic>e</italic>., a mean 12.7 years total follow-up (range 5.5 to 20.7) (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>).</p>
                <p>Plasma samples obtained during the first (n = 24) or the second (n = 9) collections were uniformly HCV RNA negative by standard clinical testing (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). However, when the same samples were re-analyzed using RT-PCR/NAH assay, 58.3% (14/24) and 44.4% (4/9) were HCV RNA reactive at mean follow-up 6.4 and 12.7 years (ranges 0.3 to 14.4 and 5.5 to 20.7 respectively) (<xref rid="pone.0140312.t002" ref-type="table">Table 2</xref> and <xref rid="pone.0140312.g001" ref-type="fig">Fig 1</xref>). The majority of HCV RNA reactive samples from the first collection (11/24; 45.8%) were positive when RNA from 250 μl plasma was analyzed. The remaining (3/14; 21.4%) were HCV RNA positive when pellets from ~5 ml of plasma were tested (<xref rid="pone.0140312.t002" ref-type="table">Table 2</xref>). Inversely, 3 of 4 (75%) plasma samples from the second collection were HCV RNA positive after ultracentrifugation (<xref rid="pone.0140312.t002" ref-type="table">Table 2</xref>). Overall, 17 of 24 (70.8%) individuals carried HCV in either one or two plasma samples collected.</p>
                <table-wrap id="pone.0140312.t002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0140312.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Total Numbers of Plasma and PBMC Samples from individuals with Spontaneous Resolution of Hepatitis C And Results on HCV Detection.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0140312.t002g" xlink:href="pone.0140312.t002"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th colspan="4" align="left" rowspan="1">Plasma</th>
                          <th align="left" rowspan="1" colspan="1">PBMC</th>
                          <th colspan="7" align="left" rowspan="1"/>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th colspan="3" align="left" rowspan="1">HCV RNA+ Positivity</th>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th colspan="3" align="justify" rowspan="1">HCV RNA+ Positivity</th>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th colspan="3" align="left" rowspan="1">HCV RNA- Positivity</th>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Sample Collection</th>
                          <th align="left" rowspan="1" colspan="1">Total Sample Tested</th>
                          <th align="left" rowspan="1" colspan="1">250 μl</th>
                          <th align="left" rowspan="1" colspan="1">5 ml</th>
                          <th align="left" rowspan="1" colspan="1">Total Positivity (%)</th>
                          <th align="left" rowspan="1" colspan="1">Total Samples Tested</th>
                          <th align="left" rowspan="1" colspan="1">PHA-Treated</th>
                          <th align="left" rowspan="1" colspan="1">C5-Treated</th>
                          <th align="left" rowspan="1" colspan="1">Total Positivity (%)</th>
                          <th align="left" rowspan="1" colspan="1">Samples Tested<xref rid="t002fn002" ref-type="table-fn">*</xref>
</th>
                          <th align="left" rowspan="1" colspan="1">PHA- Treated</th>
                          <th align="left" rowspan="1" colspan="1">C5Treated</th>
                          <th align="left" rowspan="1" colspan="1">Total Positivity (%)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">First</td>
                          <td align="left" rowspan="1" colspan="1">24</td>
                          <td align="left" rowspan="1" colspan="1">11</td>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">14/24</td>
                          <td align="left" rowspan="1" colspan="1">23</td>
                          <td align="left" rowspan="1" colspan="1">11</td>
                          <td align="left" rowspan="1" colspan="1">NA</td>
                          <td align="left" rowspan="1" colspan="1">11/23</td>
                          <td align="left" rowspan="1" colspan="1">11</td>
                          <td align="left" rowspan="1" colspan="1">11</td>
                          <td align="left" rowspan="1" colspan="1">NA</td>
                          <td align="left" rowspan="1" colspan="1">7/11</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(58.3%)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(47.8%)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(63.6%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Second</td>
                          <td align="left" rowspan="1" colspan="1">9</td>
                          <td align="left" rowspan="1" colspan="1">1</td>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">4/9</td>
                          <td align="left" rowspan="1" colspan="1">9</td>
                          <td align="left" rowspan="1" colspan="1">2</td>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">5/9</td>
                          <td align="left" rowspan="1" colspan="1">5</td>
                          <td align="left" rowspan="1" colspan="1">2</td>
                          <td align="left" rowspan="1" colspan="1">3</td>
                          <td align="left" rowspan="1" colspan="1">45</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(44.4%)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(55.6%)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(80%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>PBMC, peripheral blood mononuclear cells; HCV RNA+, HCV RNA positive strand; HCV RNA-, HCV RNA negative strand; PHA, phytohemagglutinin; C5, immune cell stimulating cocktail (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref>); NA, not applicable.</p>
                    </fn>
                    <fn id="t002fn002">
                      <p>*Tested only when the sample found HCV RNA positive strand reactive.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <fig id="pone.0140312.g001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0140312.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Detection of HCV RNA in plasma obtained at two separate collections from individuals with a past episode of spontaneously resolved hepatitis C.</title>
                    <p>Total RNA extracted from 250 μl or a pellet recovered after ultracentrifugation of ~5 ml plasma (*) acquired during the first (1) and the second (2) sample collections were amplified with 5'-UTR specific primers and amplicon specificity verified by NAH. Serial 10-fold dilutions of recombinant HCV 5'-UTR-E2 (rHCV UTR-E2) fragment carrying indicated copy numbers/reaction were used as positive and specificity controls. Water amplified in direct (DW) and nested (NW) reactions and a mock (M) extraction served as contamination controls. Positive signals showed the expected 244-bp oligonucleotide fragments. Numbers under the panels represent follow-up time in years after resolution of hepatitis C (upper line) and relative densitometric units (DU) given by hybridization signals (lower line).</p>
                  </caption>
                  <graphic xlink:href="pone.0140312.g001"/>
                </fig>
              </sec>
              <sec id="sec013">
                <title>Expression of HCV genome in PBMC years after spontaneous resolution</title>
                <p>Because of the expected very low level HCV RNA and limited availability of PBMC, cells from the first collection were stimulated <italic>ex vivo</italic> with PHA without prior testing of untreated cells, as in previous studies [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>]. In regard to PBMC acquired during the second collection, they were first cultured with PHA and, if HCV RNA positive strand was undetectable, their second sample were cultured with C5. As shown in <xref rid="pone.0140312.t002" ref-type="table">Table 2</xref>, 11 of 23 (47.8%) PHA-treated PBMC from the first collection showed HCV RNA positive strand reactivity. Also, 2 of 9 (22.2%) PBMC from the second collection were HCV RNA positive after PHA stimulation (<xref rid="pone.0140312.t002" ref-type="table">Table 2</xref>). Among the remaining 7 samples from the second collection, 3 additional displayed HCV RNA after culture in the presence of C5. In total, 5/9 (55.5%) PBMC samples collected at mean follow-up of 12.7 years (range 5.5 to 20.6 years) were HCV RNA reactive (<xref rid="pone.0140312.t002" ref-type="table">Table 2</xref>). In total, 13 of 23 (56.5%) individuals who provided either one or two PBMC samples were HCV RNA positive. Considering the results from analyses of both plasma and PBMC obtained during both collections, 70.8% (17/24) of individuals were HCV RNA positive despite being negative by conventional assays.</p>
              </sec>
              <sec id="sec014">
                <title>HCV replication in PBMC after spontaneous resolution</title>
                <p>PBMC found to be HCV RNA positive strand reactive were examined for expression of the HCV RNA negative (replicative) strand. This replication intermediate occurs at a lower copy number per cell than the positive strand and the assay detecting the negative strand is 10 to 100-fold less sensitive than that for the positive strand identification [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref020" ref-type="bibr">20</xref>], so HCV RNA negative strand was tested only in PBMC found reactive for the positive strand. Thus, this replication intermediate was detected in 11 out of 16 (68.7%) PBMC investigated (<xref rid="pone.0140312.t002" ref-type="table">Table 2</xref> and <xref rid="pone.0140312.g002" ref-type="fig">Fig 2</xref>). Among the negative strand reactive PBMC samples, 7 (7/11; 63.6%) were obtained during the first collection (mean follow-up 5.1 years) and 4 (4/5; 80%) at the second (mean follow-up 14.5 years) (<xref rid="pone.0140312.t002" ref-type="table">Table 2</xref>).</p>
                <fig id="pone.0140312.g002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0140312.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Expression of HCV RNA positive and negative (replicative) strands in PBMC samples obtained at two collections approximately 5 years apart from individuals with self-resolved hepatitis C.</title>
                    <p>(A) HCV RNA positive strand identification using 2 μg of total RNA extracted from PBMC treated <italic>ex vivo</italic> with PHA or C5 (*). (B) Detection of HCV RNA negative strand in HCV RNA positive strand reactive PBMC shown in A. Samples were obtained during the first (1) or the second (2) collection at follow-up time (years) indicated under panel A. As positive controls for HCV RNA positive strand detection, serial 10-fold dilutions of rHCV UTR-E2 carrying indicated copy numbers/reaction were used (panel A). For HCV RNA negative strand detection, synthetic HCV RNA positive strand (sHCV RNA pos) and HCV synthetic RNA negative strand (sHCV RNA neg) at 10<sup>4</sup> copies/reaction were used as positive and specificity controls, respectively (panel B). Water amplified in direct (DW) and nested (NW) reactions and a mock (M) extraction served as contamination controls. Positive signals demonstrated the expected 244-bp oligonucleotide fragments. Numbers under panels marked as relative DU represent relative densitometric units (DU) given by hybridization signals.</p>
                  </caption>
                  <graphic xlink:href="pone.0140312.g002"/>
                </fig>
              </sec>
              <sec id="sec015">
                <title>Detection of HCV in paired plasma and PBMC samples collected years apart after spontaneous resolution</title>
                <p>Examination of HCV expression in paired plasma and PBMC samples collected at two occasions 4.5 to 7.2 years apart was possible in 9 patients. Considering HCV RNA detection in either 250-μl or ~5 mL plasma and in PBMC obtained at both collections (<xref rid="pone.0140312.t003" ref-type="table">Table 3</xref>), two individuals demonstrated continued presence of low-level HCV. Hence, one (15-46/F) showed HCV in both plasma and PBMC samples at 11 and 16.1 years follow-up, while another (20-49/F) displayed virus reactivity in both plasma samples collected after 14.3 and 20.6 years and in PBMC obtained at first collection. Notably, all positive strand reactive PBMC samples (n = 3) from both cases also expressed virus RNA replicative strand (<xref rid="pone.0140312.t003" ref-type="table">Table 3</xref> and <xref rid="pone.0140312.g002" ref-type="fig">Fig 2</xref>). In another two subjects (14-47/F and 24-53/M), although the first plasma collected carried HCV RNA, plasma obtained 2.9 and 7.4 years later were virus nonreactive. Nonetheless, the final PBMC samples obtained after 7.4 and 14.1 years of follow-up, respectively, were HCV RNA positive and importantly, negative strand reactive (<xref rid="pone.0140312.t003" ref-type="table">Table 3</xref> and <xref rid="pone.0140312.g002" ref-type="fig">Fig 2</xref>). In two others (4-46/M and 16-52/F), HCV RNA was detected in plasma acquired during the second but not the first collection, whereas PBMC obtained from either the first or the second collection were HCV RNA positive strand reactive but negative for the replicative strand (<xref rid="pone.0140312.t003" ref-type="table">Table 3</xref>). In 10-70/M followed for 8.8 years, HCV was undetectable in both plasma samples, while the first PBMC sample but not the second was virus positive in the absence of the negative strand detection. Finally, paired plasma and PBMC samples collected at both bleedings from 7-73/F and 17-47/M were HCV nonreactive. These individuals were followed for 8.8 and 20.7 years, respectively, indicating that they were consistently HCV negative (<xref rid="pone.0140312.t003" ref-type="table">Table 3</xref>). Overall, considering HCV detection in the last either plasma or PBMC samples available for analysis, the majority (6/9; 66.7%) of the cases demonstrated persistence of HCV traces lasting up to 20.7 (mean 12.7) years, while 3 (33.3%) individuals were either consistently HCV negative or eliminated virus after the first sample collection.</p>
                <table-wrap id="pone.0140312.t003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0140312.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Detection of HCV in Two Sequential Paired Plasma and PBMC.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0140312.t003g" xlink:href="pone.0140312.t003"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th colspan="4" align="left" rowspan="1">First Sample Collections</th>
                          <th colspan="5" align="left" rowspan="1">Second Sample Collections</th>
                          <th align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th colspan="4" align="left" rowspan="1">HCV RNA + Strand</th>
                          <th colspan="5" align="left" rowspan="1">HCV RNA + Strand</th>
                          <th align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1">Plasma</th>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1">Plasma</th>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1">PBMC</th>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Patient Age/Sex</th>
                          <th align="left" rowspan="1" colspan="1">Genotype</th>
                          <th align="left" rowspan="1" colspan="1">250 μl</th>
                          <th align="left" rowspan="1" colspan="1">~5 ml</th>
                          <th align="left" rowspan="1" colspan="1">PBMC PHA-Treated</th>
                          <th align="left" rowspan="1" colspan="1">HCV RNA-Strand PBMC</th>
                          <th align="left" rowspan="1" colspan="1">Time from First Collection (Years)</th>
                          <th align="left" rowspan="1" colspan="1">250 μl</th>
                          <th align="left" rowspan="1" colspan="1">~5 ml</th>
                          <th align="left" rowspan="1" colspan="1">PHA-Treated</th>
                          <th align="left" rowspan="1" colspan="1">CS-Treated</th>
                          <th align="left" rowspan="1" colspan="1">HCV RNA-Strand PBMC</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">4-6/M</td>
                          <td align="left" rowspan="1" colspan="1">1b</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">5.2</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">7-73/F</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">5.5</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">10-70/M</td>
                          <td align="left" rowspan="1" colspan="1">1a</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">6.5</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">14-47/F</td>
                          <td align="left" rowspan="1" colspan="1">2a</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">4.5</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">15-46/F</td>
                          <td align="left" rowspan="1" colspan="1">3a</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">5.1</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">16-52/F</td>
                          <td align="left" rowspan="1" colspan="1">1b</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">7.2</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">17-47/M</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">6.3</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">20-49/F</td>
                          <td align="left" rowspan="1" colspan="1">1b</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">6.3</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NT</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">24-53/M</td>
                          <td align="left" rowspan="1" colspan="1">1b</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">NA</td>
                          <td align="left" rowspan="1" colspan="1">NA</td>
                          <td align="left" rowspan="1" colspan="1">6.7</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">NEG</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                          <td align="left" rowspan="1" colspan="1">POS</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Mean or Number From Total</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">2/9</td>
                          <td align="left" rowspan="1" colspan="1">2/7</td>
                          <td align="left" rowspan="1" colspan="1">4/8</td>
                          <td align="left" rowspan="1" colspan="1">1/4</td>
                          <td align="left" rowspan="1" colspan="1">5/9</td>
                          <td align="left" rowspan="1" colspan="1">1/9</td>
                          <td align="left" rowspan="1" colspan="1">3/8</td>
                          <td align="left" rowspan="1" colspan="1">2/9</td>
                          <td align="left" rowspan="1" colspan="1">3/7</td>
                          <td align="left" rowspan="1" colspan="1">4/5</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>PBMC, peripheral blood mononuclear cells; HCV RNA+, HCV RNA positive strand; HCV RNA-, HCV RNA negative strand; PHA, phytohemagglutinin; C5, immune cell stimulating cocktail (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref>); POS, positive; NEG, negative; NT, not tested; NA, not available.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec016">
                <title>Minor variations in sequence of HCV persisting after spontaneous resolution</title>
                <p>A significant effort was made to recognize sequence stability and potential compartmentalization of variants of HCV persisting after spontaneous resolution. Clones of 5’-UTR 244-bp amplicons derived from plasma and PBMC of 15-46/F (subgenotype 3a) collected at two occasions 5.1-year apart and from 20-49/F (subgenotype 1b) obtained at 14.3 and 20.6 years of follow-up were sequenced (see <xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). The resulting sequences were compared to relevant HCV sub-genotypes from GenBank and to each other taking the sequence identified in plasma from the first collection as base line (<xref rid="pone.0140312.t004" ref-type="table">Table 4</xref>). Analysis showed three types of point mutations. The first was identified in all clones derived from either plasma or PBMC obtained at both collections, which reflected variant sequences of a given sub-genotype not reported before, as a search of the published data deposited in GenBank implied, <italic>i</italic>.<italic>e</italic>., A120C and C203T in 15-46/F, and G110A and G295C in 20-49/F (<xref rid="pone.0140312.t004" ref-type="table">Table 4</xref> and <xref rid="pone.0140312.g003" ref-type="fig">Fig 3</xref>). The second type were point mutations, which occurred sporadically in one or two clones from plasma or PBMC obtained at both collections, <italic>i</italic>.<italic>e</italic>., A134G, C209T and A223C in 15-46/F, and 127insC in 20-49/F (<xref rid="pone.0140312.t004" ref-type="table">Table 4</xref> and <xref rid="pone.0140312.g003" ref-type="fig">Fig 3</xref>). The third type were very rare point mutations unique to a given compartment, <italic>i</italic>.<italic>e</italic>., plasma or PBMC, which did not have equivalence in another compartment and occurred only at one time point, <italic>i</italic>.<italic>e</italic>., C126A and T212C in 15-46/F, and A96C, C204T and G241A in 20-49/F (<xref rid="pone.0140312.t004" ref-type="table">Table 4</xref>). In general, the analysis verified that HCV persisted in both plasma and PBMC, and suggested that there was only a slight tendency towards variant compartmentalization and replication progressed at a very low rate, as inferred from the rare occurrence of point mutations unique to either plasma or PBMC.</p>
                <table-wrap id="pone.0140312.t004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0140312.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Single-Nucleotide Polymorphisms in the HCV 5’-UTR Sequence from Plasma and PBMC Obtained at Two Collections Done More than 5 Years Apart from Patients after Spontaneous Resolution of Hepatitis C.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0140312.t004g" xlink:href="pone.0140312.t004"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Patient Age/Sex</th>
                          <th align="left" rowspan="1" colspan="1">HCV Genotype</th>
                          <th align="left" rowspan="1" colspan="1">Collection (Years of Follow-up)</th>
                          <th align="left" rowspan="1" colspan="1">Sample</th>
                          <th colspan="7" align="left" rowspan="1">Point Mutations</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>A120C</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>C126A</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>A134G</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>C203T</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>C209T</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>T212C</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>A223C</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">15-26/F</td>
                          <td align="left" rowspan="1" colspan="1">3a</td>
                          <td align="left" rowspan="1" colspan="1">First (11)</td>
                          <td align="left" rowspan="1" colspan="1">Plasma</td>
                          <td align="left" rowspan="1" colspan="1">7/7</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">1/7</td>
                          <td align="left" rowspan="1" colspan="1">7/7</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">1/7</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">PBMC</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Second (16.1)</td>
                          <td align="left" rowspan="1" colspan="1">Plasma</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">PBMC</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>A96C</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>G110A</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>127<italic>ins</italic>C</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>C204T</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>G241A</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>G295C</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">20–49</td>
                          <td align="left" rowspan="1" colspan="1">1b</td>
                          <td align="left" rowspan="1" colspan="1">First (14.3)</td>
                          <td align="left" rowspan="1" colspan="1">Plasma</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1">2/10</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Second (20.6)</td>
                          <td align="left" rowspan="1" colspan="1">Plasma</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">PBMC</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">ND</td>
                          <td align="left" rowspan="1" colspan="1">1/10</td>
                          <td align="left" rowspan="1" colspan="1">10/10</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t004fn001">
                      <p>The results are presented as numbers of clones in which a given mutation was identified per total number of clones tested. The designation of the nucleotide position based on the prototype 3a and 1b subgenotype sequences D1773 and D11168, respectively, from GenBank. ND, not detected; NA, not available</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <fig id="pone.0140312.g003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0140312.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>Phylogenetic analysis of point mutations identified in the 244-bp HCV 5’-UTR fragment from plasma and PBMC of 15-46/F and 20-49/F patients with 7.4-year and 20.6-year observation periods, respectively, after spontaneous recovery from hepatitis C.</title>
                    <p>(A) HCV sequences identified in plasma and PBMCs of 15-46/F. (B) HCV sequences found in plasma and PBMCs of 20-49/F. The numbers 15 and 20 identify patient 15-46/F and 20-49/F, respectively. The numbers 1 and 2 stand for the first or the second collection of samples. The variants from plasma are marked with S and those from PBMC with P. The numbers 1–10 indicate individual clones. The nucleotide sequences of genotypes 3a and 3b for 15-46/F and 1a and 1b for 20-49/F serving as references are marked as Ref.</p>
                  </caption>
                  <graphic xlink:href="pone.0140312.g003"/>
                </fig>
                <p>Attempts to identify variants in the E1/E2 sequence encoding HVR1 were only partially successful because of limited material. Nonetheless, PBMC acquired after 16.1 and 20.6 years of follow-up of 15-46/F and 20-49/F, respectively, showed multiple point mutations common to all clones sequenced when compared to respective 3a or 1b references (<xref rid="pone.0140312.g004" ref-type="fig">Fig 4</xref>). The majority of these mutations occurred, as expected, in HVR1 and we believe not reported before. There were also very few (2–4) unique point mutations identified in one to 3 of 8 (15-46/F) or 7 (20-49/F) clones sequenced (<xref rid="pone.0140312.g004" ref-type="fig">Fig 4</xref>). This was consistent with a high degree of sequence homogeneity within and beyond HVR1 in PBMC analyzed.</p>
                <fig id="pone.0140312.g004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0140312.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>Single-nucleotide polymorphisms in the HCV E1/E2 330-bp fragment derived from PBMC of two individuals with long-term follow-up after spontaneously resolved hepatitis C.</title>
                    <p>(A) Sequence identified in PBMC after 7.4 years of observation of 15-46/F carrying HCV genotype 3a. (B) Sequence from PBMC of 20-49/F followed for 20.6 years carrying HCV genotype 1b. Seven or eight randomly selected clones were sequenced bi-directionally and their sequences compared to respective subgenotype D17763 and D11168 sequences from GenBank. The boundaries of the hypervariable region 1 (HVR1) are marked by a line. Numbers and the beginning and at the end of each reference sequence, marked as Ref, indicate nucleotide positions. Nucleotides identical to those in the reference sequence are shown as dots, different as letters, and deleted as colons.</p>
                  </caption>
                  <graphic xlink:href="pone.0140312.g004"/>
                </fig>
                <p>The 5’-UTR and E1/E2 sequences identified in this study have been deposited in GenBank under accession numbers: KP861251-KP861287 and KP861318-KP861325 for 15-46/F, and KP861288-KP861317 and KP861326-KP861332 for 20-49/F.</p>
              </sec>
              <sec id="sec017">
                <title>Inhibition of persisting HCV replication by telaprevir</title>
                <p>Treatment of PBMC reactive for HCV RNA positive and negative strands with TLP completely inhibited HCV expression in PBMC (<xref rid="pone.0140312.g005" ref-type="fig">Fig 5</xref>). Thus, PBMC from 14-47/F, 15-46/F and 20-49/F acquired during the second sample collection at 7.4, 16.1 and 20.7 years of follow-up, respectively, totally aborted expression of HCV RNA negative and positive strands after exposure to TLP, while both virus RNA strands remained detectable in control cells treated with 0.5% DMSO alone.</p>
                <fig id="pone.0140312.g005" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0140312.g005</object-id>
                  <label>Fig 5</label>
                  <caption>
                    <title>Inhibition of HCV infection in PBMC expressing initially both positive and negative strand of HCV RNA from individuals with a past spontaneous resolution of hepatitis C.</title>
                    <p>PBMC naturally infected with HCV derived from asymptomatic persons followed for 7.4 (14-47/F), 16.1 (15-46/F) or 20.6 (20-49/F) years were treated (T) with 4 μM of TLV or left untreated (UT) in culture for 72 h. Except 20-49/F PBMC, the experiment was performed in duplicate. (A) HCV RNA positive strand was detected by RT-PCR with 5’-UTR-specific primers and amplicon specificity verified by NAH. (B) Virus negative (replicative) strand was identified by the strand-specific RT-PCR/NAH in which synthetic HCV RNA positive (pos) and negative (neg) strands at 10<sup>4</sup> copies/reaction were used as specificity controls. Other controls were as described in the legend to <xref rid="pone.0140312.g002" ref-type="fig">Fig 2</xref>.</p>
                  </caption>
                  <graphic xlink:href="pone.0140312.g005"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec018">
              <title>Discussion</title>
              <p>The current study documented persistent traces of HCV in more than half (70.8%) of patients with self-limited HCV without viraemia by conventional tests when assessed by more stringent criteria. HCV carriage was evident after 6.4 and 12.7 years. HCV was identified with similar frequency in plasma (51.3%) and circulating lymphoid cells (51.1%). Examining RNA from very large amounts of plasma (~5 ml) and using PBMC stimulated <italic>ex vivo</italic> improved HCV detection rates, as observed before for SVR after IFN-based therapy [<xref rid="pone.0140312.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0140312.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0140312.ref017" ref-type="bibr">17</xref>]. The study also validates a detection approach permitting for greater uniformity and sensitivity in identification of OCI. This approach is based on cumulative experience gained during several previous studies [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0140312.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0140312.ref018" ref-type="bibr">18</xref>]. In general, HCV detection in OCI utilizes RNA prepared from large volumes of plasma and intact or mitogen-treated PBMC, testing of serial samples of plasma and circulating lymphoid cells, and detection of virus genome by assays with the greatest sensitivity possible [reviewed in 6].</p>
              <p>After spontaneous resolution of HCV infection virus-directed CD4+ and CD8+ T lymphocyte reactivity persists for decades, while humoral responses decline with time [<xref rid="pone.0140312.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0140312.ref026" ref-type="bibr">26</xref>], findings consistent with continuous stimulation of the immune system by low-level HCV replication and trace antigen production. This may be analogous to other asymptomatic carrier states following symptomatic, or unapparent, viral infection such as occult hepadnaviral persistence in humans and woodchucks after resolution of self-limited acute hepatitis or infection with very low amounts of pathogenic virus [<xref rid="pone.0140312.ref027" ref-type="bibr">27</xref>–<xref rid="pone.0140312.ref029" ref-type="bibr">29</xref>].</p>
              <p>The rate of detecting HCV RNA in the current study was comparable or lower than that reported in two previous studies using assays with similar sensitivity. In one study, 5 (71.4%) of 7 patients followed up to 5 years after transient hepatitis C were identified as HCV reactive in plasma and/or PBMC, while the HCV RNA replicative strand was detected in 2 of 4 PBMC carrying HCV RNA positive strand [<xref rid="pone.0140312.ref015" ref-type="bibr">15</xref>]. In our study that originally reported on OCI [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>], all 5 individuals followed for up to 41 years (mean 21.2 years) carried HCV traces when a single pair of plasma and PBMC was assessed by the methods used in the present work. Thus, 3 of the patients carried HCV both in plasma and PBMC, while two remaining in one of these two compartments. HCV replication was evident in 2 of 3 HCV-reactive PBMC available for the negative strand evaluation [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>]. Considering the number of patients investigated, the current study should reflect most closely the actual incidence of OCI long after spontaneously resolution of HCV. Since the similar methods to enhance HCV detection were used in all these studies, a meta-analysis of all 36 patients investigated indicate that 72.2% (n = 26) were HCV RNA trace positive when paired plasma and PBMC were analyzed. In the present investigation, testing a second pair of plasma and PBMC samples a further 4.5 to 7.2 years later confirmed OCI in 5 (55.5%). HCV was not detected in 2 (22.2%) of 9 individuals tested. Others showed a variable pattern (<xref rid="pone.0140312.t003" ref-type="table">Table 3</xref>). Some individuals clear OCI but in others the virus fluctuates at borderline detection levels for years.</p>
              <p>In the current study, approximately half of PBMC samples acquired at the mean follow-up time of 5.7 years or 13.1 years carried the HCV RNA positive strand. The majority (11/16; 68.7%) of the positive strand reactive cells were also negative strand positive (<xref rid="pone.0140312.t002" ref-type="table">Table 2</xref>), implying active virus replication. These results are similar to those in two studies in which PBMC from 4 (51.7%) of 7 individuals demonstrated HCV replication for up to 12 years [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref015" ref-type="bibr">15</xref>]. For comparison, the cumulative rate of cases with replicating virus in PBMC during OCI after clinically successful IFN-based therapy followed for up 6 years was 44.2% (46/104 individuals with OCI) [<xref rid="pone.0140312.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0140312.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0140312.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0140312.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0140312.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0140312.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0140312.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0140312.ref030" ref-type="bibr">30</xref>]. In this context, different subsets of PBMC-derived immune cells have been found to carry HCV, its RNA replication strand, intracellular non-structural protein 5a and virus sequence variants not harboured in patients’ plasma or liver [<xref rid="pone.0140312.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0140312.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0140312.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0140312.ref031" ref-type="bibr">31</xref>,<xref rid="pone.0140312.ref032" ref-type="bibr">32</xref>]. Cultured PBMC from individuals with OCI after successful antiviral therapy released HCV virion-like particles identified by immunoelectron microscopy with anti-HCV E2 antibodies and transmitted infection to virus-naïve human primary T cells [<xref rid="pone.0140312.ref009" ref-type="bibr">9</xref>]. The accumulated evidence indicates that HCV residing in immune cells retains biological competence, including infectivity [<xref rid="pone.0140312.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0140312.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0140312.ref033" ref-type="bibr">33</xref>]. Consequently, the detection of HCV positive and, in several cases, replicative strands in PBMC in the current study is indicative that both PBMC and hepatocytes are sites of HCV replication and viral assembly.</p>
              <p>Persistence of small quantities of HCV years after spontaneous resolution of HCV has several important aspects. Virologically, the long-term persistence of minute amounts of HCV is not surprising since silent carriage is common for non-cytopathic viral infection that cause chronic or clinically transient infections [<xref rid="pone.0140312.ref027" ref-type="bibr">27</xref>,<xref rid="pone.0140312.ref034" ref-type="bibr">34</xref>]. At this stage, there are insufficient data to comment on the long-term clinical consequences of OCI after apparent spontaneous resolution of HCV. In the current study, mild to severe fibrosis was found on biopsy in 3/8 with mean follow-up 7.1 years and minimal fibrosis in 4 others. In addition, fibroscan results indicative of mild fibrosis was seen in one patient after 14.1 years of observation (<xref rid="pone.0140312.t001" ref-type="table">Table 1</xref>). This is consistent with fibrosis and protracted low grade liver inflammation in some patients with OCI despite clinical SVR 10 years previously [<xref rid="pone.0140312.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0140312.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0140312.ref035" ref-type="bibr">35</xref>]. Further, HCC still develops in 3.9% despite SVR after IFN-based therapy [<xref rid="pone.0140312.ref036" ref-type="bibr">36</xref>–<xref rid="pone.0140312.ref038" ref-type="bibr">38</xref>] and OCI after spontaneous resolution of HCV may retain similar potential. Whether OCI could act as a “second hit” promoting hepatic injury in individuals with non-alcoholic fatty liver disease (NAFLD) or alcohol-related liver disease remains almost completely unexplored.</p>
              <p>As this study showed, spontaneous resolution of hepatitis C does not always coincide with molecular eradication of HCV and an established asymptomatic infection can persist for decades. This is new information that modifies our current understanding of the natural history of HCV infection. It also draws attention to issues potentially important to the pathogenicity and epidemiology of asymptomatic HCV infection that is undetectable by conventional testing, <italic>i</italic>.<italic>e</italic>., a possibility of long-term pathological consequences and subclinical transmission of virus. Overall, the results of our study imply that the long-term morbidity of asymptomatic HCV carriage should be examined even in individuals who achieve undetectable HCV after self-resolved hepatitis C and their need for anti-HCV treatment should be assessed.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec019">
              <title>Supporting Information</title>
              <supplementary-material content-type="local-data" id="pone.0140312.s001">
                <label>S1 Table</label>
                <caption>
                  <title>Sequences of oligonucleotide primers used to amplify HCV genome fragments.</title>
                  <p>(PPTX)</p>
                </caption>
                <media xlink:href="pone.0140312.s001.pptx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list>
              <title>References</title>
              <ref id="pone.0140312.ref001">
                <label>1</label>
                <mixed-citation publication-type="other">WHO (2014) Hepatitis C Fact Sheet No, 164, Updated April 2014. Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs164/en/">http://www.who.int/mediacentre/factsheets/fs164/en/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0140312.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Lavanchy</surname><given-names>D</given-names></name> (<year>2011</year>) <article-title>Evolving epidemiology of hepatitis C virus</article-title>. <source>Clin Microbiol Infect</source>
<volume>17</volume>: <fpage>107</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03432.x</pub-id>
<?supplied-pmid 21091831?><pub-id pub-id-type="pmid">21091831</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>MacParland</surname><given-names>SA</given-names></name>, <name><surname>Mulrooney</surname><given-names>PM</given-names></name>, <name><surname>Cooksley</surname><given-names>H</given-names></name>, <name><surname>Naoumov</surname><given-names>NV</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2004</year>) <article-title>Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C</article-title>. <source>J Virol</source>
<volume>78</volume>: <fpage>5867</fpage>–<lpage>5874</lpage>.
<?supplied-pmid 15140984?><pub-id pub-id-type="pmid">15140984</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Radkowski</surname><given-names>M</given-names></name>, <name><surname>Gallegos-Orozco</surname><given-names>JF</given-names></name>, <name><surname>Jablonska</surname><given-names>J</given-names></name>, <name><surname>Colby</surname><given-names>TV</given-names></name>, <name><surname>Walewska-Zielecka</surname><given-names>B</given-names></name>, <name><surname>Kubicka</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C</article-title>. <source>Hepatology</source>
<volume>41</volume>: <fpage>106</fpage>–<lpage>114</lpage>.
<?supplied-pmid 15619235?><pub-id pub-id-type="pmid">15619235</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Castillo</surname><given-names>I</given-names></name>, <name><surname>Rodriguez-Inigo</surname><given-names>E</given-names></name>, <name><surname>Lopez-Alcorocho</surname><given-names>JM</given-names></name>, <name><surname>Pardo</surname><given-names>M</given-names></name>, <name><surname>Bartolome</surname><given-names>J</given-names></name>, <name><surname>Carreno</surname><given-names>V</given-names></name> (<year>2006</year>) <article-title>Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment</article-title>. <source>Clin Infect Dis</source>
<volume>43</volume>: <fpage>1277</fpage>–<lpage>1283</lpage>.
<?supplied-pmid 17051492?><pub-id pub-id-type="pmid">17051492</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>Coffin</surname><given-names>CS</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2010</year>) <article-title>Occult hepatitis C virus infection: what does it mean?</article-title>
<source>Liver Int</source>
<volume>30</volume>: <fpage>502</fpage>–<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1111/j.1478-3231.2009.02193.x</pub-id>
<?supplied-pmid 20070513?><pub-id pub-id-type="pmid">20070513</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Shata</surname><given-names>MT</given-names></name>, <name><surname>Tricoche</surname><given-names>N</given-names></name>, <name><surname>Perkus</surname><given-names>M</given-names></name>, <name><surname>Tom</surname><given-names>D</given-names></name>, <name><surname>Brotman</surname><given-names>B</given-names></name>, <name><surname>McCormack</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Exposure to low doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees</article-title>. <source>Virology</source>
<volume>314</volume>: <fpage>601</fpage>–<lpage>616</lpage>.
<?supplied-pmid 14554088?><pub-id pub-id-type="pmid">14554088</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Katayama</surname><given-names>K</given-names></name>, <name><surname>Kumagai</surname><given-names>J</given-names></name>, <name><surname>Komiya</surname><given-names>Y</given-names></name>, <name><surname>Mizui</surname><given-names>M</given-names></name>, <name><surname>Yugi</surname><given-names>H</given-names></name>, <name><surname>Kishimoto</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission</article-title>. <source>Intervirology</source>
<volume>47</volume>: <fpage>57</fpage>–<lpage>64</lpage>.
<?supplied-pmid 15044837?><pub-id pub-id-type="pmid">15044837</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>MacParland</surname><given-names>SA</given-names></name>, <name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>Guy</surname><given-names>CS</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2009</year>) <article-title>Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro</article-title>. <source>Hepatology</source>
<volume>49</volume>: <fpage>1431</fpage>–<lpage>1441</lpage>. <pub-id pub-id-type="doi">10.1002/hep.22802</pub-id>
<?supplied-pmid 19177592?><pub-id pub-id-type="pmid">19177592</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Castillo</surname><given-names>I</given-names></name>, <name><surname>Pardo</surname><given-names>M</given-names></name>, <name><surname>Bartolome</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Occult hepatitis B virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown</article-title>. <source>J Infect Dis</source>
<volume>189</volume>: <fpage>7</fpage>–<lpage>14</lpage>.
<?supplied-pmid 14702147?><pub-id pub-id-type="pmid">14702147</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Veerapu</surname><given-names>NS</given-names></name>, <name><surname>Raghuraman</surname><given-names>S</given-names></name>, <name><surname>Liang</surname><given-names>TJ</given-names></name>, <name><surname>Heller</surname><given-names>T</given-names></name>, <name><surname>Rehermann</surname><given-names>B</given-names></name> (<year>2011</year>) <article-title>Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses</article-title>. <source>Gastroenterology</source>
<volume>140</volume>: <fpage>676</fpage>–<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2010.10.048</pub-id>
<?supplied-pmid 21040725?><pub-id pub-id-type="pmid">21040725</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>Coffin</surname><given-names>CS</given-names></name>, <name><surname>Churchill</surname><given-names>ND</given-names></name>, <name><surname>Urbanski</surname><given-names>SJ</given-names></name>, <name><surname>Lee</surname><given-names>SS</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2012</year>) <article-title>Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus</article-title>. <source>J Viral Hepat</source>
<volume>19</volume>: <fpage>103</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2893.2011.01442.x</pub-id>
<?supplied-pmid 21699630?><pub-id pub-id-type="pmid">21699630</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>AY</given-names></name>, <name><surname>Zeremski</surname><given-names>M</given-names></name>, <name><surname>Chauhan</surname><given-names>R</given-names></name>, <name><surname>Jacobson</surname><given-names>IM</given-names></name>, <name><surname>Talal</surname><given-names>AH</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2013</year>) <article-title>Persistence of hepatitis C virus during and after otherwise clinically successful treatment of chronic hepatitis C with standard pegylated interferon α-2b and ribavirin therapy</article-title>. <source>PLoS ONE</source>
<volume>8</volume>: <fpage>e80078</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0080078</pub-id>
<?supplied-pmid 24278242?><pub-id pub-id-type="pmid">24278242</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Veerapu</surname><given-names>NS</given-names></name>, <name><surname>Park</surname><given-names>S-H</given-names></name>, <name><surname>Tully</surname><given-names>DC</given-names></name>, <name><surname>Allen</surname><given-names>TM</given-names></name>, <name><surname>Rehermann</surname><given-names>B</given-names></name> (<year>2014</year>) <article-title>Trace amounts of sporadically reappearing HCV RNA can cause infection</article-title>. <source>Gastroenterology</source>
<volume>124</volume>: <fpage>3469</fpage>–<lpage>3478</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0140312.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>Mercer</surname><given-names>SE</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2009</year>) <article-title>Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles</article-title>. <source>J Viral Hepat</source>
<volume>16</volume>: <fpage>547</fpage>–<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2893.2009.01092.x</pub-id>
<?supplied-pmid 19215578?><pub-id pub-id-type="pmid">19215578</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>MacParland</surname><given-names>SA</given-names></name>, <name><surname>Coffin</surname><given-names>CS</given-names></name>, <name><surname>Lee</surname><given-names>SS</given-names></name>, <name><surname>Bursey</surname><given-names>FR</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2005</year>) <article-title>Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells</article-title>. <source>J Gen Virol</source>
<volume>86</volume>: <fpage>657</fpage>–<lpage>666</lpage>.
<?supplied-pmid 15722526?><pub-id pub-id-type="pmid">15722526</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Bartolome</surname><given-names>J</given-names></name>, <name><surname>Lopez-Alcorocho</surname><given-names>JM</given-names></name>, <name><surname>Castillo</surname><given-names>I</given-names></name>, <name><surname>Rodriguez-Inigo</surname><given-names>E</given-names></name>, <name><surname>Quiroga</surname><given-names>JA</given-names></name>, <name><surname>Palacios</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C</article-title>. <source>J Virol</source>
<volume>81</volume>: <fpage>7710</fpage>–<lpage>7715</lpage>.
<?supplied-pmid 17475654?><pub-id pub-id-type="pmid">17475654</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>King</surname><given-names>D</given-names></name>, <name><surname>MacParland</surname><given-names>SA</given-names></name>, <name><surname>McGrath</surname><given-names>JS</given-names></name>, <name><surname>Reddy</surname><given-names>SB</given-names></name>, <name><surname>Bursey</surname><given-names>FR</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection</article-title>. <source>Gastroenterology</source>
<volume>134</volume>: <fpage>812</fpage>–<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2007.12.011</pub-id>
<?supplied-pmid 18243182?><pub-id pub-id-type="pmid">18243182</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Di Liberto</surname><given-names>G</given-names></name>, <name><surname>Roque-Afonso</surname><given-names>A-M</given-names></name>, <name><surname>Kara</surname><given-names>R</given-names></name>, <name><surname>Ducoulombier</surname><given-names>D</given-names></name>, <name><surname>Fallot</surname><given-names>G</given-names></name>, <name><surname>Samuel</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Clinical and therapeutic implications of hepatitis C virus compartmentalization</article-title>. <source>Gastroenterology</source>
<volume>131</volume>: <fpage>76</fpage>–<lpage>84</lpage>.
<?supplied-pmid 16831592?><pub-id pub-id-type="pmid">16831592</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Sarhan</surname><given-names>MA</given-names></name>, <name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>Chen</surname><given-names>AY</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2012</year>) <article-title>Hepatitis C virus infection of human T lymphocytes is mediated by CD5</article-title>. <source>J Virol</source>
<volume>86</volume>: <fpage>3723</fpage>–<lpage>3735</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.06956-11</pub-id>
<?supplied-pmid 22278227?><pub-id pub-id-type="pmid">22278227</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Coffin</surname><given-names>CS</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>1999</year>) <article-title>Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis</article-title>. <source>J Clin Invest</source>
<volume>104</volume>: <fpage>203</fpage>–<lpage>212</lpage>.
<?supplied-pmid 10411550?><pub-id pub-id-type="pmid">10411550</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Carla</surname><given-names>CS</given-names></name>, <name><surname>Mulrooney-Cousins</surname><given-names>PM</given-names></name>, <name><surname>Osiowy</surname><given-names>C</given-names></name>, <name><surname>van der Meer</surname><given-names>F</given-names></name>, <name><surname>Nishikawa</surname><given-names>S</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy</article-title>. <source>J Clin Virol</source>
<volume>60</volume>: <fpage>347</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2014.04.021</pub-id>
<?supplied-pmid 24881491?><pub-id pub-id-type="pmid">24881491</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>K</given-names></name>, <name><surname>Perni</surname><given-names>RB</given-names></name>, <name><surname>Kwong</surname><given-names>AD</given-names></name>, <name><surname>Lin</surname><given-names>C</given-names></name> (<year>2006</year>) <article-title>VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>50</volume>: <fpage>1813</fpage>–<lpage>1822</lpage>.
<?supplied-pmid 16641454?><pub-id pub-id-type="pmid">16641454</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Koziel</surname><given-names>MJ</given-names></name>, <name><surname>Wong</surname><given-names>DKH</given-names></name>, <name><surname>Dudley</surname><given-names>D</given-names></name>, <name><surname>Houghton</surname><given-names>M</given-names></name>, <name><surname>Walker</surname><given-names>BD</given-names></name> (<year>1997</year>) <article-title>Hepatitis C virus-specific T cell lymphocyte and T helper cell responses in seronegative persons</article-title>. <source>J Inf Dis</source>
<volume>176</volume>: <fpage>859</fpage>–<lpage>866</lpage>.<pub-id pub-id-type="pmid">9333142</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Cramp</surname><given-names>ME</given-names></name>, <name><surname>Carucci</surname><given-names>P</given-names></name>, <name><surname>Rossol</surname><given-names>S</given-names></name>, <name><surname>Chokshi</surname><given-names>S</given-names></name>, <name><surname>Maertens</surname><given-names>G</given-names></name>, <name><surname>Williams</surname><given-names>R</given-names></name> (<year>1999</year>) <article-title>Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia</article-title>. <source>Gut</source>
<volume>44</volume>: <fpage>424</fpage>–<lpage>429</lpage>.
<?supplied-pmid 10026332?><pub-id pub-id-type="pmid">10026332</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Takaki</surname><given-names>A</given-names></name>, <name><surname>Wise</surname><given-names>M</given-names></name>, <name><surname>Maertens</surname><given-names>G</given-names></name>, <name><surname>Depla</surname><given-names>E</given-names></name>, <name><surname>Serfert</surname><given-names>U</given-names></name>, <name><surname>Liebetrau</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C</article-title>. <source>Nat Med</source>
<volume>6</volume>: <fpage>578</fpage>–<lpage>582</lpage>.
<?supplied-pmid 10802716?><pub-id pub-id-type="pmid">10802716</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Michalak</surname><given-names>TI</given-names></name>, <name><surname>Pasquinelli</surname><given-names>C</given-names></name>, <name><surname>Guilhot</surname><given-names>S</given-names></name>, <name><surname>Chisari</surname><given-names>FV</given-names></name> (<year>1994</year>) <article-title>Hepatitis B virus persistence after recovery from acute viral hepatitis</article-title>. <source>J Clin Invest</source>
<volume>93</volume>: <fpage>230</fpage>–<lpage>239</lpage>.
<?supplied-pmid 8282792?><pub-id pub-id-type="pmid">8282792</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Raimondo</surname><given-names>G</given-names></name>, <name><surname>Caccamo</surname><given-names>G</given-names></name>, <name><surname>Filomia</surname><given-names>R</given-names></name>, <name><surname>Pollicino</surname><given-names>T</given-names></name> (<year>2013</year>) <article-title>Occult HBV infection</article-title>. <source>Semin Immunopathol</source>
<volume>35</volume>: <fpage>39</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1007/s00281-012-0327-7</pub-id>
<?supplied-pmid 22829332?><pub-id pub-id-type="pmid">22829332</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Mulrooney-Cousins</surname><given-names>PM</given-names></name>, <name><surname>Chauhan</surname><given-names>R</given-names></name>, <name><surname>Churchill</surname><given-names>ND</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2014</year>) <article-title>Primary seronegative but molecularly evident hepadnaviral infection engages liver and induces hepatocellular carcinoma in the woodchuck model of hepatitis B</article-title>. <source>PLoS Path</source>
<volume>10</volume>: <fpage>e1004332</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0140312.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>Mulrooney-Cousins</surname><given-names>PM</given-names></name>, <name><surname>Mercer</surname><given-names>SE</given-names></name>, <name><surname>MacParland</surname><given-names>SA</given-names></name>, <name><surname>Inglot</surname><given-names>M</given-names></name>, <name><surname>Zalewska</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection</article-title>. <source>J Viral Hepat</source>
<volume>14</volume>: <fpage>537</fpage>–<lpage>548</lpage>.
<?supplied-pmid 17650287?><pub-id pub-id-type="pmid">17650287</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Ducoulombier</surname><given-names>D</given-names></name>, <name><surname>Roque-Afonso</surname><given-names>A-M</given-names></name>, <name><surname>Di Liberto</surname><given-names>G</given-names></name>, <name><surname>Penin</surname><given-names>F</given-names></name>, <name><surname>Kara</surname><given-names>R</given-names></name>, <name><surname>Richard</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes</article-title>. <source>Hepatology</source>
<volume>39</volume>: <fpage>817</fpage>–<lpage>825</lpage>.
<?supplied-pmid 14999702?><pub-id pub-id-type="pmid">14999702</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Pal</surname><given-names>S</given-names></name>, <name><surname>Sullivan</surname><given-names>DG</given-names></name>, <name><surname>Kim</surname><given-names>S</given-names></name>, <name><surname>Lai</surname><given-names>KK</given-names></name>, <name><surname>Kae</surname><given-names>J</given-names></name>, <name><surname>Cotler</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism</article-title>. <source>Gastroenterology</source>
<volume>130</volume>: <fpage>1107</fpage>–<lpage>1116</lpage>.
<?supplied-pmid 16618405?><pub-id pub-id-type="pmid">16618405</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>MacParland</surname><given-names>SA</given-names></name>, <name><surname>Pham</surname><given-names>TNQ</given-names></name>, <name><surname>Gujar</surname><given-names>SA</given-names></name>, <name><surname>Michalak</surname><given-names>TI</given-names></name> (<year>2006</year>) <article-title><italic>De novo</italic> infection and propagation of wild-type hepatitis C virus in human T lymphocytes <italic>in vitro</italic>
</article-title>. <source>J Gen Virol</source>
<volume>87</volume>: <fpage>3577</fpage>–<lpage>3586</lpage>.
<?supplied-pmid 17098973?><pub-id pub-id-type="pmid">17098973</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Ciure</surname><given-names>A</given-names></name>, <name><surname>Klenerman</surname><given-names>P</given-names></name>, <name><surname>Hunziker</surname><given-names>L</given-names></name>, <name><surname>Horvath</surname><given-names>E</given-names></name>, <name><surname>Odermatt</surname><given-names>B</given-names></name>, <name><surname>Ochsenbein</surname><given-names>AF</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Persistence of lymphocytic chriomeningitis virus at very low levels in immune mice</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>96</volume>: <fpage>11964</fpage>–<lpage>11969</lpage>.
<?supplied-pmid 10518559?><pub-id pub-id-type="pmid">10518559</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Hoare</surname><given-names>M</given-names></name>, <name><surname>Gelson</surname><given-names>WTH</given-names></name>, <name><surname>Rushbrook</surname><given-names>SM</given-names></name>, <name><surname>Curran</surname><given-names>MD</given-names></name>, <name><surname>Woodall</surname><given-names>T</given-names></name>, <name><surname>Coleman</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection</article-title>. <source>Hepatology</source>
<volume>48</volume>: <fpage>1737</fpage>–<lpage>1745</lpage>. <pub-id pub-id-type="doi">10.1002/hep.22484</pub-id>
<?supplied-pmid 18925639?><pub-id pub-id-type="pmid">18925639</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Kobayashi</surname><given-names>S</given-names></name>, <name><surname>Takeda</surname><given-names>T</given-names></name>, <name><surname>Enomoto</surname><given-names>M</given-names></name>, <name><surname>Tamori</surname><given-names>A</given-names></name>, <name><surname>Kawada</surname><given-names>N</given-names></name>, <name><surname>Habu</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1224 patients</article-title>. <source>Liver Intl</source>
<volume>27</volume>: <fpage>186</fpage>–<lpage>191</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0140312.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Morgan</surname><given-names>TR</given-names></name>, <name><surname>Ghany</surname><given-names>MG</given-names></name>, <name><surname>Kim</surname><given-names>H-Y</given-names></name>, <name><surname>Snow</surname><given-names>KK</given-names></name>, <name><surname>Shiffman</surname><given-names>ML</given-names></name>, <name><surname>De Santo</surname><given-names>JL</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Outcome of sustained virological responders with histologically advanced chronic hepatitis C</article-title>. <source>Hepatology</source>
<volume>52</volume>: <fpage>833</fpage>–<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1002/hep.23744</pub-id>
<?supplied-pmid 20564351?><pub-id pub-id-type="pmid">20564351</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0140312.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>van der Meer</surname><given-names>A</given-names></name>, <name><surname>Veldt</surname><given-names>BJ</given-names></name>, <name><surname>Field</surname><given-names>JJ</given-names></name>, <name><surname>Wedemeyer</surname><given-names>H</given-names></name>, <name><surname>Dufour</surname><given-names>J-F</given-names></name>, <name><surname>Lammert</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis</article-title>. <source>JAMA</source>
<volume>308</volume>: <fpage>2584</fpage>–<lpage>2595</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2012.144878</pub-id>
<?supplied-pmid 23268517?><pub-id pub-id-type="pmid">23268517</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
